Hourly refreshThu, Sep 3, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Healthcare

6,566 press releases indexed under healthcare.

AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
DownloadExcelTXT
Healthcare · Education

Before Recommending an International Student Health Insurance Company: What Five U.S. Universities Actually Require in 2026–2027

Aug 27 · 20:55PressReleaseNews
Healthcare

SpyGlass Pharma Celebrates Grand Opening of New Irvine Headquarters, Positioning Itself for First Product Launch and Custom R&D Space

Future portfolio expansion will advance a new era of ophthalmic care while driving continued growth of Irvine's MedTech and life sciences sector. IRVINE, Calif., Aug. 27, 2026 /PRNewswire/ -- SpyGlass Pharma, a biopharmaceutical clinical-stage company dedicated to transforming treatment...

Aug 27 · 20:40PR Newswire
Finance · Healthcare

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hims & Hers Health, Inc. - HIMS

NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...

Aug 27 · 20:37PR Newswire
Healthcare

Advanced Recovery Systems and Promises Behavioral Health Combine to Advance Behavioral Health Care Delivery

Advanced Recovery Systems and Promises Behavioral Health have combined, bringing together two organizations focused on evidence-based, compassionate care for people experiencing addiction and mental health conditions. [PR.com]

Aug 27 · 20:30PR.com
Finance · Healthcare

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

NEW YORK and MAINZ, GERMANY, August 27, 2026 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the companies’ 2026-2027 COVID-19 vaccine formula targeting the XFG variant (COMIRNATY ® XFG; COVID-19 Vaccine, mRNA) for use in adults ages 65 years and older, as well as in individuals ages 5 through 64 years with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. 1

Aug 27 · 20:30GlobeNewswire
Healthcare · Retail

Vanta Announces Engagement of Independent Trading Group for Market-Making ...

(PR-inside.com) VANCOUVER, BC / ACCESS Newswire / August 27, 2026 /Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences and longevity company focused on preventative wellness and healthspan extension, and parent of the Vanta premium longevity brand, announces that it has engaged the services of Independent Trading Group (ITG) Inc. ("ITG") to provide market-making services in accordance with Canadian Securities Exchange ("CSE") policies, effective August 27, 2026. The engagement of ITG forms part of the Company's broader strategic capital markets initiatives, aimed at enhancing trading liquidity, supporting orderly market conditions, and improving overall market quality for the Company's ..

Aug 27 · 20:25PR-Inside
Finance · AI

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

RESEARCH TRIANGLE PARK, N.C., August 27, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution

Aug 27 · 20:15mlpr-businesswire
Finance · Healthcare

Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines ...

(PR-inside.com) CAMBRIDGE, MA / ACCESS Newswire / August 27, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Applications (sBLA) for the 2026-2027 formulas for Spikevax® (COVID-19 Vaccine, mRNA) and mNEXSPIKE® (COVID-19 Vaccine, mRNA), containing the JN.1-lineage XFG subvariant of SARS-CoV-2 to help prevent COVID-19. The updated formula for Spikevax is now approved for individuals 6 months through 64 years of age with at least one underlying condition placing them at high risk for severe outcomes from COVID-19, and all adults 65 years of age and older. mNEXSPIKE, Moderna's latest ..

Aug 27 · 19:57PR-Inside
Healthcare

Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines

Aug 27 · 19:56Newswire.com
Healthcare

American College of Lifestyle Medicine Annual Conference to highlight lifestyle medicine implementation, clinical value and successful behavior change

The American College of Lifestyle Medicine (ACLM) has announced a full lineup of 145 keynote and concurrent sessions for its accredited, hybrid 2026 Lifestyle Medicine Annual Conference, set for November 8 to 11. The event presentations will showcase implementation of lifestyle medicine...

Aug 27 · 19:52PR Newswire
AI · SaaS

Hoomanely Unveils AI-Native Platform to Build the Health Intelligence ...

(PR-inside.com) By Learning an Animal's Patterns Over Its Lifetime, the Company Aims to Make Interspecies Health Communication Possible During an 18-Month Beta, EverBowl Generated More Than 5 Million Multimodal Data Points Across 80-Plus Dogs PALO ALTO, CA / ACCESS Newswire / August 27, 2026 / Every day, animals reveal information about their health through how they eat, drink, move, sound and behave. Today, Hoomanely unveiled an AI-native platform designed to gather these signals and translate them into individualized, longitudinal health intelligence. (Left to Right) Vipin Ravindran (CTO)_Harshal Hinger (COO)_Sai Supriya Sharath (CEO) with dog Starting with dogs, the platform learns what is normal for each ..

Aug 27 · 19:45PR-Inside
Healthcare

Vadzo Imaging Validates Onvif Profile S, T, and G on Innova-234MGS AR0234 2MP Monochrome Gigabit Ethernet Camera for Patient Monitoring Applications

Built for continuous patient monitoring and clinical imaging that must resolve motion accurately without adding heat or complexity to a patient room, this camera pairs the Onsemi AR0234 global shutter sensor with Onvif compliance and low operational power over GigE Vision, giving healthcare technology providers dependable monochrome imaging that integrates directly with hospital network infrastructure already in place.

Aug 27 · 19:30Newswire.com
← Prev123548Next →